News

16 November 2022

Figures of Indonesia Indigenous Modern Medicine Receive Honorary Title of Adjunct Professorship from Atma Jaya Catholic University

Dr. Raymond Rubianto Tjandrawinata, a leading figure in Indonesia Indigenous Modern Medicine (OMAI), was awarded the honorary title of Adjunct Professor in Pharmaceutical Biotechnology by the Indonesian Catholic University (Unika) Atma Jaya Jakarta. Dr. Raymond Rubianto Tjandrawinata has demonstrated a scientific discovery and contribution to the advancement of pharmaceutical biotechnology,…
9 November 2022

Dexa Group Leader's Public Lecture at Sanata Dharma University: Building Independence as a Dexa Group Contribution

Mr. Ferry Soetikno, the leader of the Dexa Group, served as a speaker during the Sanata Dharma University Yogyakarta Public Lecture. During his guest lecture, Mr. Ferry covered two subjects for hundreds of University of Sanata Dharma students and graduates: the introduction of Dexa Medica and the independence of pharmaceuticals…
4 November 2022

Dexa Group's Strategic Support for Indonesian Pharmacy Resilience and Independence: Indonesia Indigenous Modern Medicine Phytopharmaceutical

The pharmaceutical business is still working toward independence and health security due to the changes in the market brought on by the pandemic circumstances, the global financial crisis, and the high US Dollar exchange rate against the Rupiah. Dexa Group presented three significant initiatives for pharmaceutical resilience and independence with…
6 July 2022

Mr. Ferry A. Soetikno as a Speaker at the Advisory Board Sharing Session #7: Drug Raw Material Independence as a Part of the Dynamics of the Indonesian Pharmaceutical Industry

The Covid-19 epidemic has given Indonesia's pharmaceutical sector a fresh start. In stark contrast to the average 5–10% growth rate, the pharmaceutical sector shrank by -1.6 percent. Meanwhile, a supply shock made it challenging for the nation to get medical raw materials (BBO) since imports met 90% of BBO requirements.…
1 July 2022

Actively Contributing to Overcoming Health Problems, Dexa Group Wins Indonesia Best CSR Award 2022

Dexa Group received the Outstanding Program in Prioritizing Public Health Needs award from Warta Ekonomi's Indonesia Best CSR Award 2022 for its contribution to the healthcare industry. This honor is granted in recognition of Dexa Group's significant work putting social responsibility and environmental responsibility initiatives into action. On Thursday, June…
25 June 2022

The 'Bangga Buatan Indonesia' Movement Promotes Pharmacy Product Independence

Dexa Group participated in the Proudly Made in Indonesia 2022 event once more to accelerate the independence of domestic local products. On Thursday, June 23, 2022, the Bangga Buatan Indonesia (BBI) event with the title Lagawi Fest (Lampung Bangga Wirausaha Industri Festival) Satu Bumi Juta Karya was held on Tegal…
14 June 2022

STIMUNO Wins Top Brand For Kids for the 12th Time

STIMUNO has served as Indonesia's first phytopharmaceutical immunomodulator for over two decades. It also has won several honors since its initial release in 1999. For the 12th year in a row, STIMUNO syrup won the Top Brand For Kids Awards in the Children's Immune System Vitamins category. Marketing Magazine and…
9 June 2022

35 Health Offices in Central Java Support the Use of Indonesian Indigenous Modern Medicines

The ‘Bangga Buatan Indonesia’ Movement (BBI) is supported by 35 District/City Health Offices in Central Java Province, which provide the Special Allocation Fund (DAK) and the APBD for health expenditure on Indonesian Indigenous Modern Medicines (OMAI). Thie program is not just to comply with Presidential Instruction (Inpres) No. 2 of…
20 May 2022

Dexa Group Wins IMACO Awards 2022 for Consistently Developing Indonesian Indigenous Modern Medicines Product Innovations

Dexa Group, was named the Indonesia Most Acclaimed Company (IMACO) 2022 in the Healthcare Industry category for Outstanding Corporate Strategy for Innovative Business by Warta Ekonomi. This award validates Dexa Group's commitment as a national pharmaceutical company to continue innovating via competitive product research and development to achieve pharmaceutical independence.…
13 May 2022

HerbaASIMOR Products Aid in the Reduction of Stunting Rates

According to the Indonesia Nutrition Status Survey (SSGI), in 2021, the prevalence of stunting in Indonesia will be 24.4 percent, a 6.4 percent decrease from 30.8 percent in 2018. To meet the goal of reducing stunting prevalence to 14 percent by 2024, the Population Agency and the National Family Planning…